Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1975-03-27
1976-12-21
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
4242485, 424250, 42424854, A61K 3147
Patent
active
039989542
ABSTRACT:
1,3(2H,4H)-Dioxoisoquinoline-4-carboxamides, nuclear unsubstituted and substituted, are prepared by reacting the appropriate homophthalimide with potassium cyanate. Secondary carboxamides are prepared by reacting homophthalimide with appropriate isocyanates, and tertiary carboxamides are prepared by aminolysis of 4-carbalkoxy compounds, which are in turn prepared by alcoholysis of the corresponding 4-carboxanilides. Corresponding 5,6,7,8-tetrahydro compounds are similarly prepared. The various 2-substituted homophthalimides are prepared by reacting homophthalic acid with appropriate amine. The 4-carboxamides are anti-inflammatory agents.
REFERENCES:
patent: 3726875 (1973-04-01), Kadin
patent: 3886163 (1975-05-01), Kadin
Pfizer Inc.
Schenkman Leonard
LandOfFree
1,3(2H,4H)-Dioxoisoquinoline-4-carboxamides used as anti-inflamm does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,3(2H,4H)-Dioxoisoquinoline-4-carboxamides used as anti-inflamm, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,3(2H,4H)-Dioxoisoquinoline-4-carboxamides used as anti-inflamm will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1839445